Concepedia

Suryaprakash Vaddi

SV

Statistics

Publications

4

Citations

103

H-Index

4

Active since

2021

Affiliations

Yashoda Hospital(Current)

Kyushu University of Medical Science

Institute for Stem Cell Biology and Regenerative Medicine

University of Yamanashi

University of Toronto

Suryaprakash Vaddi is an author at Yashoda Hospital specializing in inflammation, pharmacology, and hepatoprotective agents.

Publications per year

2021–2022

4

Publications

4

Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study

Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Suryaprakash Vaddi et al. · Biomedicine & Pharmacotherapy · 2021 · 39 citations · Full text

, , +10

Hepatoprotective Effects of Aureobasidium pullulans Derived β 1,3–1,6 Glucans in a Murine Model of Non-alcoholic Steatohepatitis

Nobunao Ikewaki, Gary Levy, Gene Kurosawa et al. · Journal of Clinical and Experimental Hepatology · 2022 · 33 citations · Full text

, , +16

Hepatoprotective effects of Aureobasidium pullulans derived Beta 1,3-1,6 biological response modifier glucans in a STAM- animal model of non-alcoholic steatohepatitis

Nobunao Ikewaki, Gene Kurosawa, Masaru Iwasaki et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 20 citations · Full text

, , +17

Beneficial immune-regulatory effects of novel strains of Aureobasidium pullulans AFO-202 and N-163 produced beta glucans in Sprague Dawley rats

Nobunao Ikewaki, Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya et al. · Clinical Immunology Communications · 2021 · 11 citations · Full text

, , +11

1–4 of 4